際際滷shows by User: pkuiken / http://www.slideshare.net/images/logo.gif 際際滷shows by User: pkuiken / Thu, 23 Apr 2015 13:28:53 GMT 際際滷Share feed for 際際滷shows by User: pkuiken Regulatory Affairs Outsourcing Considerations and Models /pkuiken/regulatory-consulting-service-outsourcing-considerations-and-models 05consultingserviceoutsourcingconsiderationsandmodels-150423132853-conversion-gate01
I present a number of issues which are being considered by all organisations in the healthcare, pharmaceutical, biotechnology, and clinical sectors. I presented this to an audience at an outsourcing summit and have tailored this to a more general audience. I am happy to receive your comments and provide your insights to whether you agree or not with my points or to hear from you regarding your experiences of outsourcing in whatever sector you are interested in.]]>

I present a number of issues which are being considered by all organisations in the healthcare, pharmaceutical, biotechnology, and clinical sectors. I presented this to an audience at an outsourcing summit and have tailored this to a more general audience. I am happy to receive your comments and provide your insights to whether you agree or not with my points or to hear from you regarding your experiences of outsourcing in whatever sector you are interested in.]]>
Thu, 23 Apr 2015 13:28:53 GMT /pkuiken/regulatory-consulting-service-outsourcing-considerations-and-models pkuiken@slideshare.net(pkuiken) Regulatory Affairs Outsourcing Considerations and Models pkuiken I present a number of issues which are being considered by all organisations in the healthcare, pharmaceutical, biotechnology, and clinical sectors. I presented this to an audience at an outsourcing summit and have tailored this to a more general audience. I am happy to receive your comments and provide your insights to whether you agree or not with my points or to hear from you regarding your experiences of outsourcing in whatever sector you are interested in. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/05consultingserviceoutsourcingconsiderationsandmodels-150423132853-conversion-gate01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> I present a number of issues which are being considered by all organisations in the healthcare, pharmaceutical, biotechnology, and clinical sectors. I presented this to an audience at an outsourcing summit and have tailored this to a more general audience. I am happy to receive your comments and provide your insights to whether you agree or not with my points or to hear from you regarding your experiences of outsourcing in whatever sector you are interested in.
Regulatory Affairs Outsourcing Considerations and Models from Paul Kuiken
]]>
1356 2 https://cdn.slidesharecdn.com/ss_thumbnails/05consultingserviceoutsourcingconsiderationsandmodels-150423132853-conversion-gate01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0
https://cdn.slidesharecdn.com/profile-photo-pkuiken-48x48.jpg?cb=1573568846 Regulatory Affairs, Project Management, Strategy, Advice, Emerging markets, CMC, Clinical Trial Applications, Head of Department, Global services, Biotechnology, New product submissions, Development, Small molecules, Personnel management, Line management, Training and development, Business development, EMA, MHRA, HPRA, FDA www.pharmalinkconsulting.com